
### [NCIT:C27696](http://purl.obolibrary.org/obo/NCIT_C27696)
**Label:** EBV-Related Post-Transplant Lymphoproliferative Disorder

**Subclasses:** [NCIT:C27695](http://purl.obolibrary.org/obo/NCIT_C27695) (EBV-Related Clonal Post-Transplant Lymphoproliferative Disorder), [NCIT:C7239](http://purl.obolibrary.org/obo/NCIT_C7239) (Hodgkin-Like Post-Transplant Lymphoproliferative Disorder), [NCIT:C7243](http://purl.obolibrary.org/obo/NCIT_C7243) (Classical Hodgkin Lymphoma Type Post-Transplant Lymphoproliferative Disorder), 

**Class expressions from DL-Learner:**

- [NCIT:C38759](http://purl.obolibrary.org/obo/NCIT_C38759) (EBV Infection) 55.56%
- [NCIT:C38439](http://purl.obolibrary.org/obo/NCIT_C38439) (Mature Lymphocyte) 55.56%
- [NCIT:C50764](http://purl.obolibrary.org/obo/NCIT_C50764) (Lymphadenopathy) and (not ([NCIT:C39620](http://purl.obolibrary.org/obo/NCIT_C39620) (Dermatopathic Lymphadenopathy))) 55.56%
- Thing 52.40%
- [NCIT:C50764](http://purl.obolibrary.org/obo/NCIT_C50764) (Lymphadenopathy) 40.91%
- [NCIT:C50764](http://purl.obolibrary.org/obo/NCIT_C50764) (Lymphadenopathy) and (not ([NCIT:C40152](http://purl.obolibrary.org/obo/NCIT_C40152) (Serous Endometrial Intraepithelial Carcinoma))) 40.91%
- [NCIT:C50764](http://purl.obolibrary.org/obo/NCIT_C50764) (Lymphadenopathy) and (not ([NCIT:C40151](http://purl.obolibrary.org/obo/NCIT_C40151) (Grade 3 Endometrial Mucinous Adenocarcinoma))) 40.91%
- [NCIT:C50764](http://purl.obolibrary.org/obo/NCIT_C50764) (Lymphadenopathy) and (not ([NCIT:C40150](http://purl.obolibrary.org/obo/NCIT_C40150) (Grade 2 Endometrial Mucinous Adenocarcinoma))) 40.91%
- [NCIT:C50764](http://purl.obolibrary.org/obo/NCIT_C50764) (Lymphadenopathy) and (not ([NCIT:C40149](http://purl.obolibrary.org/obo/NCIT_C40149) (Grade 1 Endometrial Mucinous Adenocarcinoma))) 40.91%
- [NCIT:C50764](http://purl.obolibrary.org/obo/NCIT_C50764) (Lymphadenopathy) and (not ([NCIT:C40148](http://purl.obolibrary.org/obo/NCIT_C40148) (Grade 3 Endometrial Endometrioid Adenocarcinoma))) 40.91%
- [NCIT:C50764](http://purl.obolibrary.org/obo/NCIT_C50764) (Lymphadenopathy) and (not ([NCIT:C40147](http://purl.obolibrary.org/obo/NCIT_C40147) (Grade 2 Endometrial Endometrioid Adenocarcinoma))) 40.91%
- [NCIT:C50764](http://purl.obolibrary.org/obo/NCIT_C50764) (Lymphadenopathy) and (not ([NCIT:C40146](http://purl.obolibrary.org/obo/NCIT_C40146) (Grade 1 Endometrial Endometrioid Adenocarcinoma))) 40.91%
- [NCIT:C50764](http://purl.obolibrary.org/obo/NCIT_C50764) (Lymphadenopathy) and (not ([NCIT:C40142](http://purl.obolibrary.org/obo/NCIT_C40142) (Uterine Ligament Papillary Cystadenoma Associated with von Hippel-Lindau Disease))) 40.91%
- [NCIT:C50764](http://purl.obolibrary.org/obo/NCIT_C50764) (Lymphadenopathy) and (not ([NCIT:C40141](http://purl.obolibrary.org/obo/NCIT_C40141) (Wolffian Adnexal Tumor))) 40.91%
- [NCIT:C50764](http://purl.obolibrary.org/obo/NCIT_C50764) (Lymphadenopathy) and (not ([NCIT:C40139](http://purl.obolibrary.org/obo/NCIT_C40139) (Uterine Ligament Clear Cell Adenocarcinoma))) 40.91%


